Clinical Trial Results

CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus

PHASE1, PHASE2INTERVENTIONAL Philadelphia, Pennsylvania

RECRUITING

Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders

PHASE1, PHASE2INTERVENTIONAL Houston, Texas +1 more

RECRUITING

Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis

PHASE1INTERVENTIONAL Bethesda, Maryland

RECRUITING

UC-MSC Cell Therapy Study for Systemic Lupus Erythematosus (SLE) Patients

PHASE1INTERVENTIONAL Charleston, South Carolina

RECRUITING

Comparative Effectiveness of Online 8-session CBT vs. 1-Session Empowered Relief for Chronic Pain - The PROGRESS Study

NAINTERVENTIONAL Phoenix, Arizona +4 more

RECRUITING

Helping Lupus Patients Manage Fibromyalgia Symptoms Through Emotional Awareness and Expression Therapy (EAET)

NAINTERVENTIONAL Salt Lake City, Utah

RECRUITING

Safety and Efficacy of ONT01 in Lupus

EARLY_PHASE1INTERVENTIONAL New York, New York

RECRUITING

The BRIDGE Pain Study

N/AOBSERVATIONAL Cincinnati, Ohio

RECRUITING

Direct to Patient Minimal Risk Biospecimen and Data Collection Research

N/AOBSERVATIONAL Lexington, Massachusetts

RECRUITING

Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research

N/AOBSERVATIONAL Delafield, Wisconsin

RECRUITING

A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)

PHASE3INTERVENTIONAL Upland, California +4 more

RECRUITING

A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease

PHASE3INTERVENTIONAL Los Angeles, California +4 more

RECRUITING

An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants

PHASE3INTERVENTIONAL Phoenix, Arizona +4 more

RECRUITING

Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus Nephritis (SIRIUS-LN Extension)

PHASE3INTERVENTIONAL Orchard Park, New York +4 more

RECRUITING

A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus

PHASE3INTERVENTIONAL Anniston, Alabama +4 more

RECRUITING

A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

PHASE3INTERVENTIONAL Avondale, Arizona +4 more

RECRUITING

A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus

PHASE3INTERVENTIONAL Beverly Hills, California +4 more

RECRUITING

Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease

PHASE3INTERVENTIONAL Los Angeles, California +4 more

RECRUITING

A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment

PHASE3INTERVENTIONAL Doral, Florida +4 more

RECRUITING

Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).

PHASE3INTERVENTIONAL Anniston, Alabama +4 more

RECRUITING

The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients With Systemic Lupus Erythematosus (SLE) - IFN-CVD

PHASE2INTERVENTIONAL Bethesda, Maryland

RECRUITING

Transcutaneous Vagus Nerve Stimulation in SLE

PHASE2INTERVENTIONAL Manhasset, New York

RECRUITING

A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis

PHASE2INTERVENTIONAL Chicago, Illinois +3 more

RECRUITING

A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)

PHASE2INTERVENTIONAL Beverly Hills, California +4 more

RECRUITING

VIBRANT: VIB4920 for Active Lupus Nephritis

PHASE2INTERVENTIONAL La Jolla, California +4 more

RECRUITING